Global COVID-19 Diagnostics Market Forecast to 2025 with Q3,2021 Update of 2020 Actual Figures

DUBLIN--(BUSINESS WIRE)--The "Global COVID-19 Diagnostics Market Forecast by Technology, Product, Channel and Country: Assay Volumes and Market Size Outlook to 2025 - Updated to Include 2020 Actuals" report has been added to ResearchAndMarkets.com's offering.

A new dynamic market is emerging for COVID-19-based diagnostics. Testing is moving into physicians' offices and even into the home.

Saliva tests? Handheld multiplex testers? Home based testing sticks? And what about the workplace market where safety is paramount? And what happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in our latest report.

Revenue, testing volumes, technology, products and channels - they are all looked at in this complete report that provides detailed breakdowns by country and regions. Get on top of the situation quickly with market guides and situation analysis.

Companies Mentioned

• Abacus Diagnostica
• Abbott Diagnostics
• Accelerate Diagnostics
• Acces Bio
• Advanced Biological Laboratories
• Agena Bioscience, Inc
• Agilent/Dako
• Altona Diagnostics
• Alveo Technologies
• Anatolia Geneworks
• Applied BioCode
• Applied DNA Sciences
• Assurance Scientific Laboratories
• Aus Diagnostics
• Autobio Diagnostics
• Beckman Coulter Diagnostics
• Becton, Dickinson and Company
• BGI Genomics Co. Ltd
• BillionToOne
• Binx Health
• Bio-Rad Laboratories, Inc
• Bio-Reference Laboratories
• Biocartis
• Biodesix Inc
• BioFire Diagnostics (bioMerieux)
• Biolidics Ltd
• bioMerieux Diagnostics
• Bioneer Corporation
• Bosch Healthcare Solutions GmbH
• Cepheid (Danaher)
• Chembio
• Co Diagnostics
• Color Genomics
• And Many More Companies!

Key Topics Covered:

1 Market Guides

2 Introduction and Market Definition

3 The Pandemic Overview

4 Diagnostic Company Profiles

5 COVID-19 Diagnostics Recent Developments

5.1 Recent Developments - Importance and How to Use This Section

5.1.1 Importance of These Developments

5.1.2 How to Use This Section

5.2 LetsGetChecked Closes $150M Funding Round

5.3 Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay

5.4 Abbott Sees Sharp Decline in COVID-19 Test Revenue

5.5 Phosphorus Diagnostics Gets EUA for DTC C19 Test, Sample Collection Kit

5.6 NY Times Explores Multiplex Testing

5.7 Hologic Banking on MDx Acquisitions

5.8 Demand for Cepheid SARS-CoV-2 Point-of-Care Tests to Continue Through 2022

5.9 DiaSorin Acquires Luminex to Broaden MDx Portfolio, Expand US Presence

5.10 LumiraDx to Go Public Through SPAC

5.11 Eurofins Test Helps to ID Mutations

5.12 Roche Sees Growing Opportunities for Diagnostics

5.13 Roche to Acquire GenMark Diagnostics for $1.8B

5.14 Fulgent Genetics is to Use COVID-19 Testing Gains to Grow Clinical Sequencing

5.15 LexaGene Syndromic Panel Platform Lets Labs Customize Targets

5.16 FDA Grants EUAs for DTC Sample Collection Kit, Two Molecular Tests

5.17 At-Home Infectious Disease Test Developer Lucira Health Goes Public

6 The Global Market for COVID-19 Diagnostics

7 Global COVID-19 Diagnostic Markets - By Technology

8 Global COVID-19 Diagnostic Markets - By Product

9 Global COVID-19 Diagnostic Markets - By Channel

10 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/84ypmv